Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids
Clinical trial NCT01069120 · TERMINATED
Trial details
- NCT number
- NCT01069120
- Sponsor
- Repros Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2009-08-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.